2016 American Transplant Congress Archives - Page 179 of 180

P-Glycoprotein Function: Association with Race, Gender and Tacrolimus Pharmacokinetics.

K. Tornatore,^1,4 H. Minderman,² K. Attwood,³ K. O'Loughlin,² R. Venuto.⁴
Pancreas After Islet Transplantation – A Successful Treatment Option After a Failed Islet Transplant.

R. Gruessner, N. Ozden, V. Whittaker, V. Aggarwal, A. Gruessner.
Pancreas Retransplantation – Is It Worth It?

M. Kocik,¹ K. Lipar,¹ L. Janousek,¹ P. Girman,² J. Fronek,¹ F. Saudek.²
Pancreas Transplantation from Pediatric Donors: A UNOS Registry Analysis.

M. Spaggiari, I. Tzvetanov, H. Jeon, E. Benedetti, J. Oberholzer.
Pancreatic Allograft Failure in Latino Recipients: Diabetes Mellitus Type 2 Conversion?

H. Fernandez, G. McKenna, N. Onaca, R. Ruiz.
Parainfluenza-3 Infections Early After Kidney Transplantation.

I. Helanterä,¹ V.-J. Anttila,² M. Lempinen.¹
Parameters of Uremia-Associated Premature Ageing of Peripheral T Cells Do Not Predict Infectious Complications After Renal Transplantation.

B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.
Pathogenic Role of Anti-HLA Antibodies on Endothelial Progenitor Cell Dysfunction of Highly Sensitized Kidney Transplanted Patients.

V. Cantaluppi,¹ S. Dellepiane,² D. Medica,² G. Tognarelli,² M. Quaglia,¹ C. Musetti,¹ A. Airoldi,¹ L. Biancone.²
Patients Treated with Belatacept Show Low Levels of APRIL and HLA Antibodies.

M. Rial,¹ N. Ambrosi,² F. Caro,² D. Curcio,¹ J. Salaberry,² O. Guardia,¹ A. Dotta,¹ D. Guerrieri,² K. Padros,³ E. Chuluyan,² D. Casadei.
Patients with ESRD Due to Diabetes Have Higher Variability of Their Tacrolimus Levels and Worse Outcomes.

D. Goodall, M. Willicombe, A. McLean, D. Taube.
PD-L1/PD-L2-Expressing B-1a Cells Inhibit Allo-Reactive T Cells in Mice.

T. Hirose,^1,2 Y. Tanaka,¹ H. Ohdan.¹
Pediatric Access to Kidney Transplantation Under KAS.

W. Cherikh,¹ D. Stewart,¹ A. Kucheryavaya,¹ M. Aeder,² E. Brewer.³
Pediatric Critical Care Education Impacts Pediatric Organ Donation.

D. Lebovitz,¹ T. Nakagawa,² C. Wright.³
Pediatric En Bloc Kidney Transplants Reduce DGF and Are Misrepresented by the KDPI.

M. Khan,¹ H. El-Hennawy,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² M. Gautreaux,³ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
Pediatric Heart Transplantation Across a Positive Cross-Match Is Associated with High Rates of AMR but No Difference in Short Term Graft Loss, Dysfunction and Death (CTOTC-04 study).

S. Webber,¹ L. Addonizio,² E. Blume,³ A. Dipchand,⁴ R. Shaddy,⁵ B. Feingold,⁶ C. Canter,⁷ D. Hsu,⁸ W. Mahle,⁹ A. Zeevi,⁶ K. Much,¹⁰ D. Ikle,¹⁰ H. Diop,¹¹ J. Odim, MD, PhD, for CTOTC-04 Investigators.¹¹
Pediatric Kidney Transplantation and Mortality: Distance to Transplant Center Matters.

J. Adler, Y. Bababekov, J. Markmann, D. Chang, H. Yeh.
Pediatric Liver Transplant Exception Request Narratives – How Do We Justify Requests?

H. Braun,³ S. Rhee,¹ J. Dodge,² J. Roberts,² E. Perito.¹
Pediatric Patients Benifit from Steroids Free Regimen After Kidney Transplantation: A Meta-Analysis.

R. Deng, H. Zhang, Y. Zheng, L. Liu, C. Wang.
Pediatric Split Liver Transplantation: Single Center Experience.

A. Elsabbagh,^1,2 C. Williams,¹ R. Girlanda,¹ C. Desai,¹ J. Hawksworth,¹ A. Kroemer,¹ C. Matsumoto,¹ T. Fishbein.¹
Peer Mentoring to Improve Access to Kidney Transplantation in the Southeast.

J. Gander,¹ S. McMath,² M. Rudd,² L. Sauls,³ S. Tripathi,¹ L. Plantinga,¹ L. McPherson,¹ T. Browne,⁴ S. Pastan,¹ R. Patzer.¹
Peri-Operative Events and Complications in Minimally-Invasive Live Donor Nephrectomy: What Should We Tell Potential Donors?

K. Kortram, J. Ijzermans, F. Dor.
Periodical Peer Review of a Pancreas Transplant Programme: Can It Enhance Performance?

Z. Moinuddin, A. Arif, O. Masood, A. Tavakoli, R. Pararajsingam, K. Poulton, J. Worthington, B. Forgacs, T. Augustine, R. Dhanda.
Peritransplant Costimulation Blockade Combined with a Short-Course of Rapamycin Prevents Rejection of Vascularized Composite Allografts.

B. Oh, G. Furtmüller, M. Fryer, P. Akre, D. Cooney, W. Lee, G. Raimondi, G. Brandacher.
Personal Relationships and Financial Outcomes in Living Liver Donors.

A. DiMartini,¹ M. Dew,¹ Q. Liu,² M. Simpson,³ D. Ladner,⁴ A. Smith,^2,5 J. Zee,² S. Abbey,⁶ B. Gillespie,⁵ R. Weinrieb,⁷ S. Mandell,⁸ R. Fisher,⁹ J. Emond,¹⁰ C. Freise,¹¹ Z. Butt.⁴
Persufflation Improves Viability and Function of Porcine Kidneys Relative to Static Cold Storage.

C. Min,¹ L. Steyn,² A. Pandey,³ R. Harland,² J.-P. Galons,⁴ K. Papas.²
Pharmacist Impact on Medication Errors in a Chronic Kidney Transplant Clinic.

K. Covert,¹ C. Mardis,¹ J. Fleming,¹ A. Mardis,¹ H. Meadows,¹ N. Pilch,¹ P. Mohan,² M. Posadas,² M. Salazar,² T. Srinivas,² G. Mour,² D. Taber.¹
Pharmacokinetic Evaluation of Astagraf XL® and Prograf® in Renal Transplant Candidates Following Laparoscopic Sleeve Gastrectomy.

A. Lichvar,¹ A. Leino,¹ T. Kaiser,¹ T. Mizuno,² T. Fukuda,² U. Christians,¹ R. Alloway,¹ A. Vinks,² E. Woodle,¹ T. Diwan.¹
Pharmakokinetics of Prolonged-Release Formulation of Tacrolimus: Comparison of AUC0-24 and Concentration at 10 Time Points.

K. Unagami,¹ M. Okumi,² M. Furusawa,² T. Hirai,² T. Shimizu,² K. Omoto,² M. Inui,² H. Ishida,² K. Nitta,¹ K. Tanabe.²
Phenotype and Outcome of Antibody-Mediated Rejection Due to Pre-Existing and De Novo DSA in Kidney Recipients.

O. Aubert,¹ A. Loupy,¹ L. Hidalgo,² J. Reeve,³ D. Glotz,¹ C. Legendre,¹ C. Lefaucheur,¹ P. Halloran.³
Physical Disability on the Liver Transplant Waitlist: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.

M. Samoylova, M. Haftek, S. Shiboski, K. Covinsky, J. Roberts, J. Lai.
Planning Genitourinary Vascularized Composite Allotransplantation: A Pre-Operative Imaging Protocol.

I. Schol, T. Drijkoningen, G. Choy, R. Liu, C. Tanrikut, P. Holzer, D. Ko, C. Cetrulo.
Plasma Alemtuzumab Levels Show Great Interpatient Variability, but Are Not Associated with Late Acute Rejection in Simultaneous Pancreas-Kidney Recipients.

J. Bank,¹ M. Mallat,¹ C. Jol-van der Zijde,² R. Bredius,² P. van der Boog,¹ A. Braat,³ J. Ringers,³ M. Reinders,¹ J. de Fijter.¹
Plasma Cell Frequency in Renal Rejection After Treatment with Alemtuzumab.

L. Mugge, A. Zimmerman, N. Varshney, A. Gohara, M. Rees, J. Ortiz.
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.

D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²
Pneumocystis Pneumonia Following Solid Organ Transplantation, Systematic Review and Meta-Analysis.

S. Hosseini-Moghaddam,^1,2 R. Krishnan.²
Polyclonal Treg Adoptive Therapy for Control of Subclinical Kidney Transplant Inflammation (TASK Pilot Trial).

S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.
Polyfunctionality of CD8 T Cell Responses to Cytomegalovirus in Transplant Patients.

L. Higdon,¹ K. Margulies,² J. Maltzman.^1,3
Poor HLA Matching May Reduce the Beneficial Effect of ABOi Pairs Entering the Paired and Pooled Scheme.

M. Willicombe, C. Lawrence, R. Charif, A. McLean, J. Galliford, D. Taube.
Porcine Islets Engineered to Display SA-FasL Protein on Their Surface Induce Tolerance in Mice Following Transplantation into the Liver or Under the Kidney Capsule.

H. Zhao,¹ K. Woodward,¹ H. Shirwan,¹ M. Graham,² B. Hering,² E. Yolcu.¹
Porcine Islets Engineered with SA-FasL Protein Induces Robust Tolerance in Mice through CD4⁺CD25⁺FoxP3⁺ Treg Cells.

K. Woodward,¹ H. Zhao,¹ H. Shirwan,¹ F. Wang,¹ M. Graham,² B. Hering,² E. Yolcu.¹
Portal Vein Complication After Living Donor Right Hepatectomy.

D.-H. Jung, S.-G. Lee, S. Hwang, K.-H. Kim, C.-S. Ahn, D.-B. Moon, T.-Y. Ha, G.-W. Song, W.-J. Kim, S.-H. Kim, W.-H. Kang, J.-H. Kwon, E.-K. Jwa, H.-D. Cho.
Portal Venous Flow Volume Measurements May Aid Intraoperative Management of Large Portosystemic Shunts During Pediatric Liver Transplantation.

T. Pshak,¹ J. Roach,² F. Karrer,² M. Wachs.²
Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid Organ Transplant Recipients.

D. Newland, A. Edwards, R. Hall, P. Maxwell.
Positive Lymphocytes Flow Cytometry Crossmatch Due to AT1r Antibodies in Absence of HLA-DSA.

M. Ramirez,¹ D. Kershaw,² Y. Huang,² J. Magee,³ M. Samaniego,² T. Williams,¹ D. Schauss,¹ T. Franks,¹ Y. Kleyman,¹ D. Ramon.¹
Post Transplantation High-Dose Cyclophosphamide Treatment Promotes Immune Tolerance After Skin, Solid Organ, and Vascularized Composite Allotransplantation.

G. Furtmüller,¹ B. Oh,¹ M. Fryer,^1,4 P. Akre,¹ S. Ganguly,² J. Dodd-o,³ D. Cooney,¹ G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹
Post-Donation eGFR and Hypertension in Living Kidney Donors.

A. Massie,¹ A. Muzaale,¹ S. Anjum,¹ J. Leanza,¹ J. Alejo,¹ J. Locke,² D. Segev.¹
Post-Transplant Monitoring of Donor-Specific Anti-HLA Antibodies and Their Characteristics Improves Risk Stratification of Kidney Allograft Loss.

D. Viglietti,¹ A. Loupy,² C. Bentlejewski,³ C. Legendre,² D. Glotz,¹ A. Zeevi,³ C. Lefaucheur.¹
Post-Transplant Reduction of Long Lived Plasma Cells from Peripheral Circulation Is Associated with Acute Rejection in Kidney Transplant Recipients.

R. Minz,¹ R. Dhital,² M. Minz,² R. Nada,³ A. Sharma,² S. Singh,² D. Kenwar.²
Post-Transplant T-Cell Alloreactive Perturbation Precedes the Advent of Humoral Immunity in Kidney Transplant Patients.

E. Crespo,¹ S. Luque,¹ J. Cruzado,² E. Melilli,² J. Grinyo,² M. Lucia,¹ O. Bestard.²
Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.

G. Malat,⁴ S. DiLollo,¹ D. Lee,² A. Sharma,³ T. Bias,² M. Harhay,³ K. Ranganna,³ A. Doyle.³
Post-Transplantation Hypomagnesemia as a Predictor of Survival Among the Kidney Transplant Population.

T. Hod, B. Patibandla, A. Chandraker.
Post-Trial Experience with Belatacept: A Large Single Center Experience.

A. Adams, C. Garrett, J. Goldstein, R. Zhang, A. Guasch, S. Pastan, R. Patzer, A. Kirk, T. Pearson, C. Larsen.
Posterior Reversible Encephalopathy Syndrome After Pediatric Heart Transplantation: Increased Risk for Children with Preexisting Glenn/Fontan Physiology.

M. Kemna,¹ B. Eilers,² E. Albers,¹ Y. Law.¹
Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation – Is Prophylactic Treatment Necessary?

H. Ishida, T. Kondo, T. Shimizu, T. Nozaki, K. Tanabe.
Posttransplant AT1Rabs Precede De Novo HLA-DSA Development.

J. Arreola-Guerra,³ E. Cuevas,¹ E. Hernandez-Mendez,¹ M. Vilatoba,¹ A. Contreras,¹ J. Ramirez,¹ D. de Rongs,¹ J. Granados,¹ L. Morales-Buenrostro,² J. Alberu.¹
Potent Induction Therapy Improves Graft Outcome in Younger Pancreas Transplant Recipients (<30 Years of Age).

A. Gruessner, V. Whittaker, S. Narsipur, V. Aggarwal, C. Hubbel, R. Gruessner.
Potential Applications of Viral miRNA Assays in the Management of Transplant Patients with Polyomavirus BK Infection.

P. Randhawa, G. Zeng, Y. Huang.
Potential Biomarkers and Treatment for BK Virus Associated Nephropathy.

M. Borkar,¹ V. Srivastava,² R. Cunnington,¹ T. Sharma,¹ L. Tibbles.¹
Potential Kidney Donors with Asymptomatic Micorsocpic Hematuria: Histopathological Findings & Outcomes.

E. Hassan,^1,2 H. Aleid,¹ T. Zulfiquar,¹ I. Ibrahim,^1,3 H. Almana.⁴
Pre-Donation Weight Loss Postpones Living Kidney Donation without Attaining the Desired Weight Maintenance in the Midterm.

P. Ventura-Aguiar, E. De Sousa-Amorim, J. Campistol, F. Diekmann, F. Oppenheimer, I. Revuelta.
Pre-Emptive Kidney Transplantation with Living- Donor and Concomitant Unilateral Nephrectomy in Patients with Autosomal-Dominant Polycystic Kidney Disease: A Safe Strategy?

C. Michel,¹ F. Audenet,¹ M. Ariane,¹ C. Legendre,² D. Joly,² A. Méjean,¹ M.-O. Timsit.¹
Pre-Existing Chronic Heart Failure in Kidney Transplantation: An Underestimated Risk Factor for Graft Loss?

F. Halleck, D. Khadzhynov, L. Lehner, E. Schrezenmeier, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Pre-Existing Diabetes Mellitus Type 2 and Insufficiently Controlled Post-Transplant HbA1c in Kidney Transplantation.

F. Halleck, D. Khadzhynov, L. Lehner, E. Schrezenmeier, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Pre-Formed AT1R Antibodies Are Associated with Rejection After Kidney Transplantation.

D. Kim, P. Warner, K. Nelson, I. Gimferrer, C. Johnson, C. Blosser, R. Bakthavatsalam, N. Leca.
Pre-Listing Prescription Narcotic Use: Survival Implications in Liver Transplantation.

H. Randall,^1,6 K. Lentine,⁶ D. Segev,^2,1 H. Yuan,⁶ J. Tuttle-Newhall,³ M. Nazzal,⁶ C. Varma,⁶ G. Hess,⁵ B. Kasiske,¹ M. Schnitzler.^6,1
Pre-Mortem Cannulation and NECMO Preservation for DCD Liver Transplantation.

P. Ruiz,¹ M. Gastaca,¹ A. Valdivieso,¹ A. Ventoso,¹ I. Palomares,¹ M. Prieto,¹ J. Bustamante,² P. Salvador,² J. Ortiz de Urbina.¹
Pre-Transplant Anti-A Titers in Waitlisted A2 to B Kidney Transplant Candidates.

D. Moore, I. Feurer, R. Forbes, A. DeMers, D. Shaffer.
Pre-Transplant Bariatric Surgery and One-Year Graft Loss Risk in Kidney Transplants.

G. Mour, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.
Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea.

J. An,^1,2 S. Ahn,³ E. Bae,² E. Kang,² H.-L. Kim,⁴ Y.-J. Kim,⁵ Y. Oh,^1,2 C. Lim,^1,2 Y. Kim,² Y. Kim,⁶ J. Lee.^1,2
Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?

D. Khadzhynov, F. Halleck, L. Lehner, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Pre-Transplant IgM to Post-Transplant IgG DSA Conversion May Be Affected by Immunosuppression.

A. Nguyen,¹ M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,² C. Morgan,² A. Maldonado,² P. Terasaki.¹
Pre-Transplant Infusion of Extracorporeal Photopheresis Treated Donor Splenocytes Leads to Long-Term Liver Allograft Survival and Donor Specific Tolerance in Rats.

X. Kang,¹ Y. Xie,² X. Yeap,² J. Wang,² J. Schneiderman,² Z. Zhang.²
Pre-Transplant Intra-Arterial Liver Directed Therapy Does Not Increase the Risk of Hepatic Arterial Misadventures in Liver Transplantation.

J. Kallini,² A. Gabr,² R. Salem,² R. Lewandowski,² T. Baker.¹
Pre-Transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-Transplant Outcomes: A National Study.

M. Nazzal,¹ J. Chen,¹ K. Lentine,¹ M. Schnitzler,¹ J. Tuttle-Newhall,² C. Varma,¹ A. Taha,¹ A. Said,¹ H. Xiao,¹ H. Randall.¹
Pre-Transplant Panel of Reactive T Cells (PRT) as an Independent Predictor of 2-Year Kidney Graft Function.

I. Gandolfini,¹ E. Crespo,² M. Baweja,¹ U. Maggiore,³ P. Cravedi,¹ P. Heeger,¹ O. Bestard.²
Pre-Transplant Prostate Cancer in Lung Transplant Recipients and Impact on Post-Transplant Morbidity and Mortality.

S. Ajani, M. Valapour, M. Budev.
Pre-Transplant Risk Factors: Predicting Nonadherence and Rejection in Adult Liver Transplant Recipients.

S. Lieber,¹ J. Helcer,¹ E. Leven,¹ C. Knight,² C. Wlodarkiewicz,² A. Shenoy,¹ E. Shemesh,¹ S. Florman,³ T. Schiano,³ R. Annunziato.¹
Predicting and Reducing 30-Day Readmission After Liver Transplant (OLT).

K. Eid, M. Elshamy, L. Louwers, B. Eghtesad, C. Quintini, K. Snyder, F. Aucejo, K. Hashimoto, M. Fujiki, C. Miller, D. Kelly.
Predicting Delayed Kidney Graft Function with Gene Expression in Preimplantation Biopsies.

T. Mourão,^1,3 K. Mine,¹ E. Campos,^1,3 J. Medina-Pestana,^2,3 H. Tedesco-Silva,² M. Gerbase-De Lima.
Predicting Early Cardiac Death After Kidney Transplantation.

K. Balabhadrapatruni, A. Liu, N. Sarabu, E. Sanchez, J. Augustine.
Predicting Emergence of Anti-HLA Class I and II Antibodies by Time Dependent Phenomapping in Heart Transplant Patients.

M. Bakir, N. Jackson, E. Chang, D. Henriquez-Ticas, C.-H. Tseng, T. Khuu, J. Zhang, E. Reed, M. Deng, M. Cadeiras.
Predicting Late Medication Non-Adherence in Adult Kidney Transplant Recipients.

D. Taber, A. Posadas, A. Chokkalingam, R. Browning, N. Salazar, M. Kamel, R. Pullalarevu, B. Kadri, K. Chavin, T. Srinivas, P. Baliga.
Predicting Obstructive Coronary Artery Disease in Asymptomatic Patients Undergoing Renal Transplantation Using a Simple Risk Score.

D. Moutzouris, C. Baker, M. Willicombe, N. Duncan, J. Galliford, A. McLean, D. Taube.
Predicting Survival to Listing for Liver Transplantation: Do MELD and Race Interact?

M. Jesse, E. Goldstein, N. Rebhan, C.-X. Ho, T. Macaulay, M. Bebanic, L. Shkokani, D. Moonka, M. Abouljoud, A. Yoshida.
Predicting the Ability of Anti-HLA Antibodies to Activate Complement.

D. Bekbolsynov, C. Baum, B. Mierzejewska, A. Malebari, M. Rees, S. Stepkowski.
Predicting the Timing of Graft Failure in De Novo DSA Positive Patients.

M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,³ C. Morgan,² A. Maldonado,⁴ A. Nguyen,¹ P. Terasaki.¹
Prediction of Patient Survival After Kidney Transplantation: Construction, Validation and Evaluation of Decision Models Using Data Mining Approaches.

I. Scheffner,¹ K. Hua,² D. Simovici,² T. Abeling,¹ H. Haller,¹ W. Gwinner.¹
Predictive Factors of Early Hospital Readmission in Liver Transplant Recipients.

A. Hilliard, M. Brokhof, J. Geyston, J. DeMott, E. Chan, M. Hertl, N. Alvey.
Predictive Model for Medication Errors in a Chronic Kidney Transplant Clinic.

K. Covert,¹ C. Mardis,¹ J. Fleming,¹ A. Mardis,¹ H. Meadows,¹ N. Pilch,¹ P. Mohan,² M. Posadas,² M. Salazar,² T. Srinivas,² G. Mour,² D. Taber.¹
Predictive Model of Delayed Graft Function in Machine Perfused Kidney Transplantation: Model Validation Using Decision Curve Analysis.

K. Ravindra,¹ S. Sanoff,¹ D. Vikraman,¹ U. Patel,¹ M. Ellis,¹ E. Squires,² D. Sudan,¹ W. Irish.¹
Predictive Value of Preoperation Serum Gamma-Glutamyltranspeptidase for Hepatocellular Carcinoma Prognosis After Liver Transplantation.

S. Fu, Q. Zhao, M. Chen, L. Wu, Q. Ren, F. Ji, Z. Guo, X. He.
Predictors of Donor Heart Utilization in United States.

J. Trivedi, A. Cheng, E. Schumer, M. Black, H. Massey, M. Slaughter.
Predictors of Early Rejection and Allograft Failure in Pediatric Kidney Transplantation: Impact of Histology and Behavior.

M. Seifert, M. Yanik, R. Mannon.
Predictors of eGFR Slope at One Year in Kidney Transplants – A Big Data Approach.

J. Zhang, Z. Su, D. Taber, J. Marsden, W. Moran, P. Mauldin, T. Srinivas.
Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.

R. Evans,¹ N. Neville,² A. Fugit,³ R. Gedaly,¹ T. Clifford.¹
Predictors of Patient Uncertainty Regarding Treatment Options Among End Stage Renal Disease Patients Evaluated for Kidney Transplantation.

L. McPherson,¹ M. Basu,¹ S. Pastan,¹ S. Mohan,² M. Wolf,³ J. Gander,¹ R. Patzer.¹
Predictors of Post Transplant Lymphoprolipherative Disorder Among Adult Kidney Transplant Recipients.

M. Mohamed, S. Parajuli, B. Muth, A. Djamali, B. Astor.
Predictors of Postoperative Cardiovascular Complications Until Three Months After Kidney Transplantation.

M. Slot,^1,2 J. van de Wetering,¹ M. Kho,¹ M. Betjes,¹ J. Roodnat.¹
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma in Cirrhotic Livers.

M. Samoylova, N. Mehta, J. Roberts, F. Yao.
Predictors of Urologic Complications After Pediatric En-Bloc Donor Kidney Transplantation.

S. Kabagambe,¹ A. De Mattos,² R. Perez,¹ C. Santhanakrishnan,¹ J. Sageshima,¹ C. Troppmann,¹ J. McVicar.¹
Prednisone Wean After Dual Heart and Kidney Transplantation: Is There a Risk?

D. Chang, J. Patel, M. Kittleson, T. Aintablian, L. Czer, D. Ramzy, J. Kobashigawa.
Predonation Prescription Narcotic Use: A Novel Risk Factor for Readmission After Living Donor Nephrectomy.

K. Lentine,^1,7 D. Segev,^2,1 D. Axelrod,³ N. Lam,⁴ A. Garg,⁵ G. Hess,⁶ B. Kasiske,¹ D. Brennan,⁸ H. Randall,⁷ M. Schnitzler.^7,1
Preemptive CMV Prophylaxis in Renal Transplant Recipients Receiving Everolimus Immunosuppression Reduces Cytomegalovirus Infection.

G. Spagnoletti, M. Salerno, V. Bianchi, N. Silvestrini, F. Apponi, J. Romagnoli.
Preformed Antibodies Against AT₁R and EDNRA Correlate with Rejection Post-Transplant.

A. Gareau,¹ C. Wiebe,^1,2 D. Pochinco,² I. Gibson,³ D. Rush,¹ P. Nickerson.^1,2,4
Pregnancy Excludes Women from Successful Living Donor Transplantation.

P. Porrett,¹ B. Bromberger,² S. Hashmi,¹ A. Morrison,¹ D. Sawinski.³
Pregnancy in the Renal Transplant Recipient: Pregnancy Viability and Effects on Graft Function.

A. Lima, M. Cristelli, C. Teixeira, I. Pietrobom, G. Basso, L. Viana, M. de Paula, C. C[acirc]ndido, H. Tedesco-Silva, J. Pestana.
Pregnancy Outcomes in 17 Female Heart Transplant Recipients with the Initial Diagnosis of Congenital Heart Defect.

L. Coscia,¹ D. Armenti,¹ S. Constantinescu,^1,2 M. Moritz.^1,3
Preimplant Donor Histology Does Not Improve Discrimination of 5 Year Kidney Allograft Outcomes.

C. Traynor,¹ T. Dorman,² D. de Freitus,² P. Conlon,² C. O'Seaghdha.²
Preimplantation and Post-Transplant Serial Biopsies of Standard and Extended Criteria Donor Kidneys: Intragraft Molecular Profiles and Effect of Different Immunosuppressive Protocols.

C. Mazeti,¹ H. Caldas,¹ I. Fernandes-Charpiot,² M. Baptista,² M. Abbud-Filho.^1,2,3
Preoperative Cytokine Storm in High MELD Patients Accentuates Incidence of Rejection Following Liver Transplantation.

A. Mathur, E. Presbyskowski, E. Zorn, K. Rogers, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, T. Kato, J. Emond.
Presence of Highly Immunogenic Mismatch Eplets Is Associated with Development of Chronic Active Antibody-Mediated Rejection: A First Report from Japan.

D. Iwami, K. Morita, H. Sasaki, H. Higuchi, Y. Takada, N. Shinohara.
Preservation of Alloreactive and Antiviral Immunity After Switch to Belatacept-Based Regimen After Kidney Transplantation.

J. Schaenman,¹ Y. Korin,² T. Sidwell,² V. Groysberg,² J. Gadzhyan,¹ E. Lum,¹ U. Reddy,¹ E. Huang,¹ T. Pham,¹ G. Danovitch,¹ E. Reed,² S. Bunnapradist.¹
Pretransplant Serum Hyaluronic Acid Can Be a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

S. Mizuno,¹ B. Das,² Y. Iizawa,¹ H. Kato,¹ Y. Murata,¹ A. Tanemura,¹ N. Kriyama,¹ Y. Azumi,¹ M. Kishiwada,¹ M. Usui,¹ H. Sakurai,¹ S. Isaji.¹
Prevalence of Polyreactive Innate-Like B Cells Among Graft-Infiltrating B Cells in Human Cardiac Allograft Vasculopathy.

D. Chatterjee,¹ C. Moore,² B. Gao,³ K. Clerkin,¹ S. See,¹ D. Shaked,¹ K. Rogers,¹ S. Nunez,¹ Y. Veras,¹ L. Addonizio,¹ M. Givertz,⁴ Y. Naka,¹ D. Mancini,¹ R. Vasilescu,⁵ C. Marboe,⁵ S. Restaino,¹ J. Madsen,² E. Zorn.¹
Primary Graft Failure following Cardiac Transplantation Is Associated with Elevated Pre-Transplant Levels of Pro-Inflammatory Factors.

D. Chatterjee,¹ K. Clerkin,¹ K. Rogers,¹ D. Mancini,¹ Y. Naka,¹ H. Takayama,² K. Takeda,² P. Colombo,² G. Vlad,³ R. Vasilescu,³ B. Levin,⁴ M. Farr,¹ S. Restaino,¹ E. Zorn.¹
Primary Outcome of iWITH: A Multi-Center Clinical Trial of Complete Immunosuppression Withdrawal (ISW) in Stable Pediatric Liver Transplant (LT) Recipients.

S. Feng,¹ J. Bucuvalas,² A. Demetris,³ K. Spain,⁴ S. Kanaparthi,⁵ J. Magee,⁶ G. Mazariegos,³ The iWITH Investigators.⁷
Prior Infection or Colonization with Carbapenem-Resistant Enterobacteriaceae Is Not an Absolute Contraindication for Solid Organ Transplantation.

S. Huprikar,¹ L. Casner,¹ S. Pouch,² M. Pinheiro Freire,³ R. Madan,⁴ E. Kwak,⁵ M. Satlin,⁶ P. Hartman,⁷ L. Pisney,⁸ P. Henrique Mourão,⁹ R. La Hoz,¹⁰ G. Patel.¹
Probability of Transplant (POT) Index: A Novel Method to Predict the Likelihood of an Adult Liver Transplant.

J. Moffett,¹ M. Kueht,¹ H. Petrowsky,² I. Riaz,³ C. Nalty,⁴ S. Khaderi,¹ C. O'Mahony,¹ J. Goss,¹ A. Rana.¹
Probability, Risk Factors, and Long-Term Outcomes of Biliary Complications After Hepatic Artery Thrombosis in Adult Liver Transplant Recipients: 20 Years Experience from a Single Center.

M. Fujiki, K. Hashimoto, T. Diago, C. Quintini, F. Aucejo, D. Kelly, B. Eghtesad, J. Fung, C. Miller.
Profiling Immunologic Risk for Acute Rejection in Liver Transplantation: Recipient Age Is a Robust Risk Factor.

M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Profiling Metabolic Differences Between Graft- vs. Pathogen-Elicited CD8⁺ T Cell Responses.

A. Karp, M. Wagener, J. Robertson, M. Ford.
Profiling of T Cell Subsets in a Primate Cardiac Transplant Model.

N. O'Neill, T. Zhang, G. Braileanu, W. Sun, X. Cheng, C. Evans, R. Pierson, A. Azimzadeh.
Prognosis Value of the Presence and Persistence of C1q Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

E. Bailly,¹ B. Proust,² M. Giral,³ V. Vuiblet,⁴ V. Chatelet,⁵ E. Morelon,⁶ P. Malvezzi,⁷ S. Caillard,⁸ B. Barrou,⁹ L. Couzi,¹⁰ J. Sayegh,¹¹ C. Mousson,¹² D. Anglicheau,¹³ P. Grimbert,¹⁴ M. Hazzan,¹⁵ G. Mourad,¹⁶ R. Purgus,¹⁷ P. Westeel,¹⁸ Y. Lebranchu,^1,19 M. Büchler.^1,19
Projection versus Reality: KPSAM and KAS.

S. Gustafson, A. Israni, J. Pyke, N. Salkowski, J. Snyder, B. Kasiske.
Prolongation of Graft Survival by Anti-TIM1 Is Specifically Mediated by IL-10+ Bregs and Is Not Dependent on IL-35 or Plasma Cell Differentiation.

Y. Zhou,^1,2 Q. Ding,¹ A. Cherukuri,¹ D. Rothstein.¹
Prolonged Cold Ischemia Time Negatively Impacts Graft and Recipient Survival in a Murine Orthotopic Hindlimb Transplant Model.

N. Datta, S. Devaney, A. Allen, R. Busuttil, K. Azari, J. Kupiec-Weglinski.
Prolonged Normothermic Ex Vivo Kidney Perfusion Is a Safe Preservation Technique for Kidney Transplantation: A New Opportunity for the Storage, Assessment and Repair of Kidney Grafts.

J. Kaths,^1,2,3 J. Echeverri,¹ N. Goldaracena,¹ K. Louis,¹ Y.-M. Chun,¹ I. Linares,^1,3 A. Wiebe,¹ P. Yip,⁵ R. John,⁵ I. Mucsi,⁶ A. Ghanekar,¹ D. Bagli,^7,3 D. Grant,¹ L. Robinson,^2,3 M. Selzner.^1,3
Prolonged Pre-Transplant Dialysis Duration Reverses the “Nephroprotective Effect” in Simultaneous Liver-Kidney Transplant Recipients.

M. Casey, X. Wen, A. Santos, S. Rehman, K. Womer.
Prophylactic Anti-Virus Therapy, Is It Necessary to Occult Hepatitis B Virus Carriers with HBsAg(-) and HBcAb(+) After Kidney Transplantation?

G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang.
Prospective Investigation of the Reliability and Validity of the Live Donor Assessment Tool (LDAT).

D. LaPointe Rudow, A. Shenoy, J. Hunt, Z. Filipovic-Jewell, B. Haydel, B. Iacoviello.
Prospective Long-Term Analysis of B- and Plasma Cell Subsets in Renal Transplant Patients After Combined Treatment with Rituximab and Bortezomib in Antibody Mediated Rejection.

M. Duerr, F. Halleck, O. Staeck, L. Lehner, D. Khadzhynov, S. Eva, J. Waiser, K. Budde.
Prospective Randomized Controlled Study Evaluating the Impact of an Electronic Feedback System on Medication Adherence in Solid Organ Transplantation.

M. Lockwood, L. Potter, B. Kane, L. Lourenco, A. Bozdin, J. Millis.
Prospective Randomized Controlled Study Evaluating the Relationship Between Electronic Adherence Data and Tacrolimus Concentration Data.

B. Kane,¹ M. Lockwood,¹ L. Potter,¹ L. Lourenco,¹ A. Bodzin,¹ D. Covington,² K. Mayer,³ J. Millis.¹
Prospective Randomized OPEN Trial Designed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in DE NOVO Kidney Transplant Recipients Two-Year Results.

R. Esmeraldo, M. Oliveira, P. Pinheiro, C. Girao, T. Freitas.
Prospective Randomized Study of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant.

A. Shetty, O. Traitanon, M. Ansari, J. Mathew, J. Leventhal, V. Mas, L. Gallon.
Prospective Single Antigen Bead Epitope-Based Clustering for Early Detection of Antibody Mediated Rejection.

A. Lichvar, S. Tremblay, P. Brailey, A. Girnita, R. Alloway, E. Woodle.
Prostate Cancer Characteristics and Outcome in Renal Transplant Recipients: Results from a Contemporary Monocentric Study.

C. Pettenati,¹ A.-S. Jannot,² V. Verkarre,³ S. Hurel,¹ H. Kreis,⁴ M. Housset,⁵ C. Legendre,⁴ A. Méjean,¹ M.-O. Timsit.¹
Protective Effects of Nrf2 Over-Activation in Myeloid Cells During Hepatic Ischemia Reperfusion Correlates with Stat3 Signaling in Hepatocytes.

C. Harberg,¹ L.-Y. Lee,¹ S. Werner,² D. Johnson,³ J. Johnson,³ D. Foley.¹
Protective Impact of the Kidney in SPK Transplants – Mechanisms for Improved Outcomes Compared with Solitary Transplants.

E. Finger, T. Dunn, A. Kukla, V. Kirchner, R. Kandaswamy.
Proteoforms: Novel Biomarkers for Acute Rejection in Liver Transplant Recipients.

J. Levitsky,¹ T. Toby,¹ K. Kim,¹ I. Ntai,¹ A. Demetris,² M. Abecassis,¹ P. Thomas,¹ N. Kelleher.¹
Protocol for Health Information Exchange Living Donor Cohort Discovery.

M. Henderson,¹ A. Roberts,² A. Massie,³ D. Segev,³ W. Goggins,¹ C. Stone,¹ B. Dixon.^1,2
Provider Attitudes Toward Shared Mobile Decision Aid Utilized Among Patients Evaluated for Kidney Transplantation: iChoose Kidney Randomized Trial.

M. Basu,¹ S. Pastan,¹ S. Mohan,² M. Wolf,³ J. Friedewald,³ D. Ladner,³ K. Smith,¹ L. McPherson,¹ A. Russell,³ M. Chiles,² R. Patzer.¹
Psychiatric Characteristics of Acute Liver Failure Patients: Acetaminophen Overdose versus Other Etiologies.

N. Rebhan, M. Bebanic, A. Yoshida, T. Macaulay, E. Goldstein, C.-X. Ho, A. Eshelman, M. Abouljoud, M. Jesse, M. Rizzari.
Psychosocial Factors Associated with Medication Adherence Based on Self Reports in Kidney Allograft Recipients: Baseline Findings from the PRIMA (ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application) Study.

A. Han,¹ C. Choi,¹ S.-Y. Kim,¹ S. Cho,¹ M.-J. Cho,¹ C. Lee,¹ S. Ahn,¹ S.-I. Min,¹ S.-K. Min,¹ I. Jung,¹ S. Kim,² M. Park,³ J. Ha.^1,3
Pulmonary Hypertension in Renal Transplant Candidates: A Systematic Review and Meta-Analysis of the Available Evidence.

A. Moza,¹ A. Khan,² R. Prashar,³ S. Khan,¹ S. Khouri,¹ S. Vetteth,¹ D. Malhotra,¹ M. Rees,¹ G. Moukarbel,¹ J. Ortiz.¹
Pulse Pressure and GFR Decay in Kidney Transplant Recipients.

O. Sanchez, S. Reule, R. Spong, N. Issa, A. Kukla, A. Matas, H. Ibrahim.
Pulse Wave Velocity Amongst African-American Kidney Transplant Recipients Randomized to Once-Daily MeltDose Tacrolimus Tablets (Envarsus XR) vs. Traditional Twice-Daily Tacrolimus Capsules: Exploratory Results from a Phase III Trial.

J. Trofe-Clark,^1,2 R. Townsend,² R. Neubauer,² M. Lim,² L. Callahan,³ R. Bloom.²